Anxiety, panic disorder medication recalled over potential foreign substance

Updated: Oct. 27, 2019 at 3:55 PM CDT
Email This Link
Share on Pinterest
Share on LinkedIn

(WAFB) - The U.S. Food and Drug Administration (FDA) is alerting the public about a recall of one lot of Alprazolam Tablets. The medication is being recalled due to the potential presence of a foreign substance.

Alprazolam Tablets are used to manage anxiety disorder, provide short-term relief for anxiety symptoms, and treat panic disorder, according to the FDA.

Mylan Pharmaceuticals Inc. is conducting the voluntary nationwide recall.

The recalled medications are packaged in bottles of 500 and were distributed in the U.S. between July 2019 and August 2019. They can be identified using the information below.

NDCProduct Description and StrengthSizeLot numberExpiry
0378-4003-05Alprazolam Tablets, USP C-IV 0.5 mgBottles of 5008082708September 2020

To date, Mylan has not received any adverse events related to this batch.

According to the FDA, Mylan has notified its distributors and customers and is arranging for return of all recalled products.

Consumers with questions about this recall can call Mylan Customer Relations at 800-796-9526 or send an email to

Copyright 2019 WAFB. All rights reserved.